Redetermination of the structure of olmesartan medoxomil, (5-methyl-2- oxo-2H-1,3-dioxol-4-yl)-methyl-4-(2-hydroxypropan-2-yl)-2-propyl-1-(-[2- (2H-1,2,3,4-tetrazol-5-yl)-phenyl]phenylmethyl)-1H-imidazole-5- carboxylate, C29H30N6O6

Redetermination of the structure of olmesartan medoxomil, (5-methyl-2- oxo-2H-1,3-dioxol-4-yl)-methyl-4-(2-hydroxypropan-2-yl)-2-propyl-1-(-[2- (2H-1,2,3,4-tetrazol-5-yl)-phenyl]phenylmethyl)-1H-imidazole-5- carboxylate, C29H30N6O6

C29H30N6O6, monoclinic, P21/c (no. 14), a = 12.3134(3) Å, b = 21.2095(4) Å, c = 10.8503(2) Å, β = 100.549(1)°, V = 2785.8 Å3, Z = 4, Rgt(F) = 0.0422, wRref(F2) = 0.1205, T = 200 K

Bibliographic Details
Main Authors: Betz Richard, Hosten Eric, Gerber Thomas, Dayananda Alaloor S., Yathirajan Hemmige S., Saji Thomas
Format: Article
Language:English
Published: De Gruyter 2013-03-01
Series:Zeitschrift für Kristallographie - New Crystal Structures
Online Access:https://doi.org/10.1524/ncrs.2013.0073

Internet

https://doi.org/10.1524/ncrs.2013.0073

Similar Items